CDKN2B-AS1 and pulmonary arterial hypertension: However, further studies are required to explore the underlying molecular mechanisms of how hypoxia-mediated downregulation of ANRIL contributes to the cellular functional alterations and pulmonary vascular remodeling in the pathogenesis of PAH.